Cover Image
市場調查報告書

HPV感染:全球臨床實驗趨勢

Human Papillomavirus Infections Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 321707
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
Back to Top
HPV感染:全球臨床實驗趨勢 Human Papillomavirus Infections Global Clinical Trials Review, H1, 2015
出版日期: 2015年06月25日 內容資訊: 英文 120 Pages
簡介

本報告提供HPV感染臨床實驗相關之最新趨勢分析,提供您各地區的臨床實驗數量,臨床實驗的各階段進展,實驗對像採用狀況,有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • HPV感染
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲的主要5個國家臨床實驗數量
    • 中南美的主要5個國家臨床實驗數量

G7各國臨床實驗數量:感染疾病治療藥臨床實驗上HPV感染的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:感染疾病治療藥臨床實驗上HPV感染的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

HPV感染治療藥臨床實驗主要的參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • GlaxoSmithKline Plc
    • Merck & Co., Inc.
    • Merck Sharp & Dohme Corp.
    • Valeant Pharmaceuticals International, Inc.
    • Medicis Pharmaceutical Corporation
    • Genticel S.A.
    • Nestle S.A.
    • BioMAS Ltd.
    • AstraZeneca Plc
    • Akela Pharma Inc. (Inactive)
  • 有代表性的研究機關·醫院臨床實驗概要
    • The National Institute of Allergy and Infectious Diseases
    • National Cancer Institute
    • AIDS Malignancy Clinical Trials Consortium
    • Leiden University Medical Center
    • Medical University of Vienna
    • Dana-Farber Cancer Institute, Inc.
    • Duke University
    • Second Affiliated Hospital of Shanxi Medical University
    • Shiraz University of Medical Sciences
    • The Johns Hopkins University

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2747CTIDB

GlobalData's clinical trial report, "Human Papillomavirus Infections Global Clinical Trials Review, H1, 2015" provides an overview of Human Papillomavirus Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Human Papillomavirus Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Human Papillomavirus Infections
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Human Papillomavirus Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Human Papillomavirus Infections to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Human Papillomavirus Infections
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Human Papillomavirus Infections Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Human Papillomavirus Infections
      • Jun 16, 2015: Genticel Receives FDA Clearance of IND Application for U.S. Phase 1 Clinical Trial of GTL001, Company's First-in-class HPV Therapeutic Vaccine Candidate
      • Apr 20, 2015: Genticel to Present Further Promising Pharmacology In-Vivo Results of Its Phase 2 Immunotherapeutic Vaccine Candidate, GTL001 (ProCervix), at AACR Annual Meeting 2015
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GlaxoSmithKline Plc
      • Clinical Trial Overview of GlaxoSmithKline Plc
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Merck Sharp & Dohme Corp.
      • Clinical Trial Overview of Merck Sharp & Dohme Corp.
      • Valeant Pharmaceuticals International, Inc.
      • Clinical Trial Overview of Valeant Pharmaceuticals International, Inc.
      • Medicis Pharmaceutical Corporation
      • Clinical Trial Overview of Medicis Pharmaceutical Corporation
      • Genticel S.A.
      • Clinical Trial Overview of Genticel S.A.
      • Nestle S.A.
      • Clinical Trial Overview of Nestle S.A.
      • BioMAS Ltd.
      • Clinical Trial Overview of BioMAS Ltd.
      • AstraZeneca Plc
      • Clinical Trial Overview of AstraZeneca Plc
      • Akela Pharma Inc. (Inactive)
      • Clinical Trial Overview of Akela Pharma Inc. (Inactive)
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • AIDS Malignancy Clinical Trials Consortium
      • Clinical Trial Overview of AIDS Malignancy Clinical Trials Consortium
      • Leiden University Medical Center
      • Clinical Trial Overview of Leiden University Medical Center
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Dana-Farber Cancer Institute, Inc.
      • Clinical Trial Overview of Dana-Farber Cancer Institute, Inc.
      • Duke University
      • Clinical Trial Overview of Duke University
      • Second Affiliated Hospital of Shanxi Medical University
      • Clinical Trial Overview of Second Affiliated Hospital of Shanxi Medical University
      • Shiraz University of Medical Sciences
      • Clinical Trial Overview of Shiraz University of Medical Sciences
      • The Johns Hopkins University
      • Clinical Trial Overview of The Johns Hopkins University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Human Papillomavirus Infections Therapeutics, Global, Clinical Trials by Region, 2015*
  • Human Papillomavirus Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Human Papillomavirus Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Human Papillomavirus Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015*
  • Human Papillomavirus Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Human Papillomavirus Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Human Papillomavirus Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2015*
  • Human Papillomavirus Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Human Papillomavirus Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Human Papillomavirus Infections Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Human Papillomavirus Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Human Papillomavirus Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Human Papillomavirus Infections Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Human Papillomavirus Infections Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Human Papillomavirus Infections Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Human Papillomavirus Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck Sharp & Dohme Corp., 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Medicis Pharmaceutical Corporation, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Genticel S.A., 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Nestle S.A., 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by BioMAS Ltd., 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Akela Pharma Inc. (Inactive), 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AIDS Malignancy Clinical Trials Consortium, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, Inc., 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Second Affiliated Hospital of Shanxi Medical University, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The Johns Hopkins University, 2015*

List of Figures

  • Human Papillomavirus Infections Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Human Papillomavirus Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Human Papillomavirus Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Human Papillomavirus Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015*
  • Human Papillomavirus Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Human Papillomavirus Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Human Papillomavirus Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2015*
  • Human Papillomavirus Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Human Papillomavirus Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Human Papillomavirus Infections Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Human Papillomavirus Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Human Papillomavirus Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Human Papillomavirus Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Human Papillomavirus Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top